Epstein-Barr virus (EBV) is a gammaherpesvirus, associated with infectious mononucleosis and various types of malignancy. We focused here on the BDLF4 gene of EBV and identified it as a lytic gene, expressed with early kinetics. Viral late gene expression of the BDLF4 knockout strain was severely restricted; this could be restored by an exogenous supply of BDLF4. These results indicate that BDLF4 is important for the EBV lytic replication cycle, especially in late gene expression.
levels of the wild-type, frameshift mutant, and revertant viruses were comparable (Fig. 3A) . Disruption of BDLF4 decreased virus yield to approximately 10% to 20% compared with levels seen with the wild-type and revertant viruses (Fig.  3B ). BDLF4 protein was not detected in the cell lysate of the frameshift mutant (Fig. 3C ). Wild-type, mutant, and revertant viruses exhibited comparable levels of expression of E genes (BALF2 and BMRF1), while the protein expression level of L genes (BALF4 [gB] and BRRF2 [8] ) in the knockout virusinfected cells was slightly, but appreciably, lower. Additionally, expression of L genes was monitored by reverse transcription-PCR (RT-PCR). As expected, the mutation in BDLF4 markedly reduced expression of MCP (BcLF1), gp350 (BLLF1), and BALF4 (gB), whereas the E gene, BALF2, was not affected (Fig.  3D ), suggesting that BDLF4 may be involved in L gene expression.
BDLF4 is responsible for viral L gene expression. As shown in Fig. 4 , we tested if exogenous supply of BDLF4 in trans could restore the reduced virus yield and L gene expression in BDLF4 mutant. In the point-mutated EBV, BDLF4 expression completely complemented the titer (Fig. 4A) . The BALF4 protein level was also recovered (Fig. 4B, BALF4 rightmost lane). Other L gene mRNA levels (MCP, gp350) could also be restored by exogenous expression of BDLF4 (Fig. 4C) .
Because KSHV, MHV-68, and HCMV homologs of BVLF1, BcRF1, BDLF3.5, BDLF4, and BGLF3 have been reported to act together in L gene regulation (4-7, 9-18), we tested if BDLF4 interacted with these factors by immunoprecipitation (Fig. 4D ). We confirmed the BGLF3, BcRF1, BVLF1, and BDLF3.5 proteins were coprecipitated with BDLF4 (Fig. 4D) . These results strongly indicate the involvement of BDLF4 protein in the regulation of L gene expression in the lytic phase of EBV infection.
Currently, it is known that BVLF1, BcRF1, BDLF3.5, BDLF4, BGLF3, and BFRF2 gene products of EBV are essential for efficient L gene transcription as monitored by luciferase assays (19) . Among these, knockout viruses of only BcRF1 and BFRF2 have been prepared and characterized (12, 19) . In this study, we newly prepared a BDLF4 mutant and provided evidence that BDLF4 plays an important role in L gene transcription.
Historically, Serio and others found that EBV L genes carry a noncanonical TATA box, TATTAAA, which can function only after de novo viral DNA replication (20) . Recently, in MHV-68, the DNA sequence required for the L gene promoter activation was mapped to a core element containing the TATT sequence and its neighboring sequences (21) . The noncanonical TATA box is crucial for HCMV L gene expression, too (22) .
The mechanisms regulating this noncanonical TATA box in betaherpesviruses and gammaherpesviruses have remained elusive, but accumulating evidence indicates that BcRF1 (or its homologs) binds to the noncanonical TATA box (10, 12, 23) , providing specificity to the L promoters. Some other components of the complex are reported to interact with and recruit RNA polymerase II (Pol II) to enhance the transcriptional start of L genes (17, 19) . It is also reported that HCMV UL79 protein also interacts with Pol II and enhances the elongation rate (15) .
Because disruption of either of the trans-acting factors can prevent L gene expression, such an attenuated virus may be a suitable candidate strain for a therapeutic live vaccine (13) . Instead, if a small-molecule inhibitor of the complex could be developed, such an inhibitor might be a useful candidate antiviral agent not only for EBV but also for KSHV, HCMV, and HHV-6/7.
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We are grateful to W. Hammerschmidt, H. J. Delecluse, T. Kanda, T. Tsurumi, S. Ohno, and H. Isomura for materials and scientific discussions. EBV and its revertant virus were generated using a BAC system in Escherichia coli (25, 26) . The neomycin resistance and streptomycin sensitivity genes (Neo/St) were inserted between nucleotides 220 (nt220) and nt221 of the BDLF4 gene. The Neo/St cassette was then replaced by a BDLF4 sequence with a one-nucleotide deletion at T (nt222) (dBDLF4-Frame). This one nucleotide excision caused frame shifting in the BDLF4 gene at residue 74 and creation of a new termination signal after synthesizing 12 nonsense, unrelated amino acids. The Neo/St cassette was again inserted and replaced with a wild-type BDLF4 sequence to make the revertant virus dBDLF4/R. (B) Electrophoresis of the recombinant viruses. EBV BAC DNAs were digested with BamHI or EcoRI and separated in an agarose gel. 5 . Immunoprecipitation (IP) was carried out using anti-Flag antibody, and the results were detected by Western blotting using anti-Myc, anti-HA, and anti-Flag antibodies. Anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a negative control. The arrowhead indicates immunoglobulin.
